Action of Matricaria recutita (chamomile) in the management of radiochemotherapy oral mucositis: A systematic review.
Matricaria
chamomile
chemotherapy
oral mucositis
radiotherapy
Journal
Phytotherapy research : PTR
ISSN: 1099-1573
Titre abrégé: Phytother Res
Pays: England
ID NLM: 8904486
Informations de publication
Date de publication:
Mar 2022
Mar 2022
Historique:
revised:
15
12
2021
received:
22
03
2021
accepted:
22
12
2021
pubmed:
8
2
2022
medline:
26
3
2022
entrez:
7
2
2022
Statut:
ppublish
Résumé
The objective of this study was to evaluate the effect of topical chamomile in the prevention and/or treatment of oral mucositis (OM) in cancer patients. It was a systematic review, which sought articles of the randomized clinical trial according to the PRISMA parameters, registered in the PROSPERO. The databases used were PubMed, Cochrane Library, and Bireme. Descriptors were selected from DeCs/MeSH and the PICO strategy was applied. The search found 148 publications. After all the steps, six articles were selected. The total sample included 492 patients and all studies used the same OM measurement scale. The results showed that the application of topical chamomile was effective in the prevention and/or treatment of OM in four of the six studies, with a dose ranging from 1% to 2.5% and duration that ranged from single to 4 times a day. Some limitations were observed: the minimum age of the patients was not informed, and there was no specification of the sites involved or the chemotherapies used. The application of topical chamomile in the preventive/therapeutic of chemo-induced OM seems to be recommended. In addition, scientific production should be encouraged, as it aims to determine useful protocols for this phytotherapy for the oncology population.
Substances chimiques
Plant Extracts
0
Types de publication
Journal Article
Review
Systematic Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
1115-1125Subventions
Organisme : Bahia Research Foundation
Informations de copyright
© 2022 John Wiley & Sons, Ltd.
Références
Ariyawardana, A., Cheng, K. K. F., Kandwal, A., Tilly, V., Al-Azri, A. R., Galiti, D., … Elad, S. (2019). Systematic review of anti-inflammatory agentes for the management of oral mucositis in cancer patients and clinical practice guidelines. Support Care in Cancer, 27, 3985-3995. https://doi.org/10.1007/s00520-019-04888-w
Bahramnezhad, F., Nayeri, N. D., Bassampour, S. S., Khajeh, M., & Asgari, P. (2015). Honey and radiation-induced stomatitis in patients with head and neck cancer. Iranian Red Crescent Medical Journal, 17(10), e19256. https://doi.org/10.5812/ircmj.19256
Barasch, A., & Peterson, D. E. (2003). Risk factors for ulcerative oral mucositis in cancer patients: Unanswered questions. Oral Oncology, 39(2), 91-100. https://doi.org/10.1016/s1368-8375(02)00033-7
Bellm, L. A., Epstein, J. B., Rose-Ped, A., Martin, P., & Fuchs, H. J. (2000). Patient reports of complications of bone marrow transplantation. Support Care Cancer, 8, 33-39. https://doi.org/10.1007/s005209900095
Braga, F. T. M. M., Santos, A. C. F., Bueno, P. C. P., Silveira, R. C. C. P., Santos, C. B., Bastos, J. K., & Carvalho, E. C. (2015). Use of Chamomilla recutita in the prevention and treatment of oral mucositis in patients undergoing hematopoietic stem cell transplantation: A randomized, controlled Phase II clinical trial. Cancer Nursing, 38, 322-9. https://doi.org/10.1097/NCC.0000000000000194
dos Reis, P. E. D., Ciol, M. A., Melo, N. S., Figueiredo, P. T. S., Leite, A. F., & Manzi, N. M. (2016). Chamomile infusion cryotherapy to prevent oral mucositis induced by chemotherapy: A pilot study. Support Care Cancer, 24, 4393-4398. https://doi.org/10.1007/s00520-016-3279-y
Fidler, P., Loprinzi, C. L., O'Fallon, J. R., Leitch, J. M., Lee, J. K., Hayes, D. L., … Michalak, J. C. (1996). Prospective evaluation of a chamomile mouthwash for prevention of 5-FU-Induced Oral mucositis. Cancer, 77, 522-525. https://doi.org/10.1002/(SICI)1097-0142(19960201)77:3<522::AID-CNCR14>3.0.CO;2-6
Higgins J.P.T., & Altman D.G. (2011). SJ (Editors). Chapter 8: assessing risk of bias in included studies. Cochrane Handb Syst Rev Interv Version 510 [internet]. [updated March 2011; cited 2020 Available from: https://doi.org/10.1001/jama.2013.109501.
Higgins J.P.T., & Green S. (2011). Cochrane handbook for systematic reviews of interventions version 5.1.0. [internet]. [updated 2011 Mar; cited 2020 Aug 10]. Available from: http://www.cochrane-handbook.org/.
Hong, C. H. L., Gueiros, L. A., Fulton, J. S., Cheng, K. K. F., Kandwal, A., Galiti, D., … Elad, S. (2019). Systematic review of basic oral care for the management of oral mucositis in cancer patients and clinical practice guidelines. Support Care in Cancer, 27, 3949-3967. https://doi.org/10.1007/s00520-019-04848-4
Izzo, A. A., Hoon-Kim, S., Radhakrishnan, R., & Williamson, E. M. (2016). A critical approach to evaluating clinical efficacy, adverse events and drug interactions of herbal remedies. Phytotherapy Research, 30, 691-700. https://doi.org/10.1002/ptr.5591
Kato, S., Saito, A., Matsuda, N., Suzuki, H., Ujiie, M., Sato, S., … Satoh, H. (2017). Management of afatinib-induced stomatitis. Molecular and Clinical Oncology, 6, 603-605. https://doi.org/10.3892/mco.2017.1184
Lalla, R. V., Bowen, J., Barasch, A., Elting, L., Epstein, J., & Keefe, D. M. (2014). MASCC/ISOO clinical practice guidelines for the manegement of mucositis secondary to cancer therapy. Cancer, 120, 1453-1561. https://doi.org/10.1002/cncr.28592
McKay, D. L., & Blumberg, J. B. (2006). A review of the bioactivity and potential health benefits of chamomile tea (Matricaria recutita L.). Phytotherapy Research, 20, 519-530. https://doi.org/10.1002/ptr.1900
Ministério da Saúde. Brasil, ANVISA. (2016). Memento Fitoterápico. Farmacopeia Brasileira. Brasília: 1 ed, 63-64.
Miraj, S., Azizi, N., & Kiani, S. (2016). A review of chemical components and pharmacological effects of Melissa officinalis L. Der Pharmacia Lettre, 8(6), 229-237.
Moher, D., Liberati, A., Tetlaff, J., & Altman, D. G. (2009). Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. PLoS Medicine, 6(7), e1000097. https://doi.org/10.1371/journal.pmed.1000097
O'Hara, M., Kiefer, D., Farrell, K., & Kemper, K. (1998). A review of 12 commonly used medicinal herbs. Archives of Family Medicine, 7, 523-536. https://doi.org/10.1001/archfami.7.6.523
Peterson, D. E. (1999). Research advances in oral mucositis. Current Opinion in Oncology, 11, 261-266. https://doi.org/10.1097/00001622-199907000-00005
Presibella, M. M., Villas-Bôas, L. B., Belletti, K. M. S., Santos, C. A. M., & Weffort-Santos, A. M. (2006). Comparison of chemical constituentsof Chamomilla recutita (L.) Rauschert essential oil and its and anti-chemotactic activity. Brazilian Archives of Biology and Technology, 49(5), 717-724. https://doi.org/10.1590/S1516-89132006000600005
Pourdeghatkar, F., Motaghi, M., Darbandi, B., & Baghersalimi, A. (2017). Comparative effect of chamomile mouthwash and topical mouth rinse in prevention of chemotherapy-induced oral mucositis in Iranian pediatric patients with acute lymphoblastic leukemia. Iranian Jorunal of Blood and Cancer, 9(3), 84-88.
Raber-Durlacher, J. E., Elad, S., & Barash, A. (2010). Oral mucositis. Oral Oncology, 46, 452-456. https://doi.org/10.1016/j.oraloncology.2010.03.012
Santos, C. M. C., Pimenta, C. A. M., & Nobre, M. R. C. (2007). A estratégia PICO para a construção da pergunta de pesquisa e busca de evidências. Rev Latino-Am Enfermagem, 15(3), 1-4. https://doi.org/10.1590/S0104-11692007000300023
Saunders, D. P., Epstein, J. B., Elad, S., Allemano, J., Bossi, P., Van de Wetering, M. D., … Lalla, R. V. (2013). Systematic review of antimicrobials, mucosal coating agentes, anesthetics, and analgesics for the management of oral mucositis in cancer patients. Support Care Cancer, 21, 3191-3207. https://doi.org/10.1007/s00520-013-1871-y
Schulz, K. F., Altman, D. G., & Moher, D. (2010). CONSORT 2010 statement: Updated guidelines for reporting parallel group randomized trials. BMJ, 340, 332-332. https://doi.org/10.1136/bmj.c332
Shabanloei, R., Ahmadi, F., Vaez, J., Ansarin, K., Hajizadeh, E., & Javadzadeh, Y. (2009). Alloporinol, chamomile and normal saline mouthwashes for the prevention of chemotherapy-induced stomatitis. J Clinic Diag Res, 3, 1537-1542.
Silverman, S., Jr. (2007). Diagnosis and management of oral mucositis. The Journal of Supportive Oncology, 5(suppl 1), 13-21.
Sonis, S. T. (2004). Pathobiology of mucositis. Seminars in Oncology Nursing, 20, 11-15. https://doi.org/10.1053/j.soncn.2003.10.003
Sonis, S. T. (2007). Pathobiology of oral mucositis: Novel insights and opportunities. The Journal of Supportive Oncology, 9(5), 3-11.
Sonis, S. T., Elting, L. S., Keefe, D., Peterson, D. E., Schubert, M., Hauer-Jensen, M., … Rubenstein, E. B. (2004). Perspectives on cancer therapy-induced mucosal injury: Pathogenesis, measurement, epidemiology, and consequences for patients. Cancer, 100(9 Suppl), 1995-2025. https://doi.org/10.1002/cncr.20162
Who Monographs on Selected Medicinal Plants. (1999). Geneva: World Health Organization, 1, 86-94.
Williamson, E. M., Liu, X., & Izzo, A. A. (2020). Trends in use, pharmacology and clinical applications of emerging herbal nutraceuticals. British Journal of Pharmacology, 77(6), 1227-1240. https://doi.org/10.1111/bph.14943
World Health Organization. (1979). Handbook for reporting results of cancer treatment (pp. 15-22). Geneva: World Health Organization.
Yarom, N., Hovan, A., Bossi, P., Ariyawardana, A., Jensen, S. B., Gobbo, M., … Elad, S. (2020). Systematic review of natural and miscellaneous agents, for the management of oral mucositis in cancer patients and clinical practice guidelines - Part 2: Honey, herbal compounds, saliva stimulants, probiotics, and miscellaneous agentes. Support Care Cancer, 28, 2457-2472. https://doi.org/10.1007/s00520-019-05256-4